Conflicts of interests
Abstract
Doctors who advertise drugs or other items in a commercial. Scientific societies that recommend treatments with trade names. In hospitals, signs advertising teachers' offices often bear the name of a pharmaceutical laboratory. The medical records with which students come into contact for the first time have the same imprint. Consensus, publications and different meetings are in the same situation. Medical training, for a great majority, depends exclusively on brochures, magazines and conferences financed by the pharmaceutical industry. Conflicts of interest have invaded everything from the doctor, institutions, regulatory agencies, governments. Countless publications and reports on the matter appear in the scientific literature, and at the same time, efforts are being made to control an aspect of medicine that ultimately harms patients.
References
(2) Carey B. Study finds a link of drug makers to psychiatrists, The New York Times, 20 de abril de 2006. Traducido por Antonio Ugalde, Obtenido http:/www.boletinfarmacos.org/062006/etica (Consulta: dic 2006)
(3) Bero LA, Rennie D. Inf1uences on the quality of published drug studies. Int J Technol Assess Health Care 1996; 12: 209-37.
(4) Chalmers I. Underreporting research in scientific misconduct. JAMA 1990; 263:1405-8.
(5) Cohen W, Florida R, Goe WR. University-industry research centers in the United States. Pittsburgh: Camegie-Mellon University Press: 1994.
(6) Gotzsche PC, Hrobjartsson A, Johansen HK, Haahr MT, Altrnan DG, Chan AW. Related Articles, Links Constraints on publication rights in industry-initiated clinical tríals. JAMA 2006; 295(14): 1645-6.
(7) Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287:612-7.
(8) Lurie P, Almeida C, Stine N, Stine AR, Wolfe SM. Financial Conf1ict of Interest Disclosure and Voting Pattems at Food and Drug Administration Drug Advisory Committee Meetings. JAMA 2006; 295:1921-8.
(9) Prescrire Rédaction "Politiques" Rev Prescrire 2005; 25(263): 481.
(10) House of Cornrnons Health Cornrnittee. The influence of the pharmaceutical industry. Fourth report of session 2004/2005. Disponible en: http://www.publications.parliament.uk/pa/cm200405/cmsel (Consulta: 22 mar 2005).
(11) Davidoff F, De Angelis CD, Drazen JM, Hoey J, Hojgaard L, Harton L, et al. Sponsorship, authorship, and accountability. Lancet 2001; 358: 854-6.
(12) International Cornrnittee of Medical Journal Editors. Uniform Requirements for Manuscripts Submitted to Biomedical Joumals: Writing and Editing for Biomedical Publication. February 2006. Web site. Available al: http://www.icmje.org. (Consulta: 23 ene 2006).
(13) Web site http://www.aamc.org/research/coi/start.htm (Consulta: 18 dic 2006)
(14) Web site http://www.cgcom.org/deonto/pdf/06_05_12_relacion_industria.pdf (Consulta: 18 dic 2006)
(15) Steinbrook R. For Sale: Physicians' Prescribing Data. N Engl J Med 2006; 354(26): 2745-7.
(16) Web site http://www.amsa.org/prof/pharmfree.cfm (Consulta: 18 dic 2006)
(17) Rotondo MT. Relaciones profesionales: conflictos de intereses. Rev Med Urug 2006; 22: 88-99.
(18) Portillo J. Reflexiones acerca de la relación médicos-empresas farmacéuticas. Rev Med Urug 1998; 14(1): 60-8.
(19) Universidad de la República. Facultad de Medicina. Las relaciones entre los servicios de Facultad y las firmas y representantes del área biomédica. (Resoluciones del Consejo de Facultad 17/VII/96 y 5/III/97). Montevideo: Universidad de la República. 1997.
